Trial Profile

A multiple-dose crossover study of Patiromer in healthy subjects.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 02 May 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Patiromer (Primary)
Indications Hyperkalaemia
Focus Pharmacodynamics

Most Recent Events

28 Dec 2016 New analyses of data from this and another phase I trial (CT profile 268635) were presented at the National Kidney Foundation (NKF) 2016 Spring Clinical Meeting, according to a Relypsa Inc. media release.
28 Apr 2016 Results of new analyses from this and another phase I trial (CT profile 268635) published in a Relypsa Inc. media release.
21 Apr 2016 According to Relypsa media release, data will be presented at National Kidney Foundation 2016 Spring Clinical Meetings.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com